Author Archive

Law Catalyst

Law Catalyst

Shire,settlement,58.9,whistleblower,sheller

The Sheller whistleblower team announced a $58.9 milllion settlement with Shire Pharmaceuticals over off-label marketing of ADHD drugs Adderall and Vyvanse in September, 2014. Court documents detailing the civil allegations and settlement were

2014-09-30 Stephen Sheller presented the feature CLE “American ‘Hustle’: Whistleblowers and Prosecuting False Claims Act Cases” at the Montgomery County Bench Bar conference September 2014. Joined by former Assistant U.S. Attorney Joseph Trautwein,

The Toronto Star 2014-06-26 By: David Bruser News Reporter, Jesse McLean Investigative News reporter, Andrew Bailey Data Analyst, Published on Thu Jun 26 2014 A 15-year-old girl who wanted to clear her acne was prescribed the antibiotic minocycline. The teen

Digital Journal 2014-04-16 The whistleblower attorney team of Sheller P.C. announced today that Astellas Pharma U.S., Inc. has agreed to pay $7.3 million to resolve allegations by the Sheller whistleblower client that Astellas violated the False

Law.com 2014-03-04 Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort.

DrexelNOW 2014-02-21 Drexel University will begin a major expansion of its nurse-managed health center which is nationally recognized as a model of integrated care. With a new gift of $2.5 million from the

2014-02-25 Sheller, P.C. announced today that Sarasota Pain Associates, P.A. (SPA) and its owner, Dr. Steven Chun, have agreed to pay $750,000 to resolve allegations by the law firm’s whistleblower clients that SPA violated

2014-01-15 J&J settles a total of six lawsuits with Sheller, P.C. clients; hundreds more represented. Sheller attorneys continue to accept new clients, but there will be a time limit for filing a claim.

Bloomberg Business Week 2013-12-09 Judy Doetterl was a sales representative for Johnson & Johnson (JNJ) in 2004 when federal agents placed a hidden recording device on her and sent her to tape marketing presentations at

11/20/2013  In the wake of the $2.2 billion settlement by Johnson & Johnson to resolve criminal and civil charges for illegal marketing of the Risperdal antipsychotic pill (more here), two of the authors